Mar 9, 2026 | Compliance, Consolidated Appropriations Act of 2021 (CAA), Pharmacy Benefits Manager (PBM), Prescription, Primary Care, RxDC report, Specialty Care, Third party administration
As you may recall, the Consolidated Appropriations Act of 2021 (CAA) requires group health plans to submit to the Centers for Medicare & Medicaid Services information about prescription drugs and health care spending. This data submission is called RxDC (for...
Nov 4, 2025 | Chronic conditions, MedBen Rx, Mental Health, Prescription, Rx Costs
A recent GoodRx list of the 20 most prescribed medications prompted MedBen Rx to take a closer look at how our own top prescriptions compare. Because GoodRx’s rankings largely reflect individuals who pay for medications out of pocket – rather than through...
Oct 6, 2025 | Independent pharmacies, Legislative, Pharmacy, Pharmacy Benefits Manager (PBM), Prescription, State legislation
Independent pharmacies across the country are facing financial strain, with many closing their doors due to unsustainable reimbursement rates and restrictive practices imposed by the major pharmacy benefit managers (PBMs). In response, states are taking legislative...
Sep 23, 2025 | Brian Fargus, Brooke Hupp, Cancer, Conferences, Cost Savings, Drug costs, Health care costs, Innovations, Pharmacy, Prescription, Rx Costs, Savings
The 12th Annual Sherrill-Morgan Healthcare Conference, held September 18-19, convened employers from Ohio, Kentucky, and Tennessee to explore innovative approaches to managing escalating healthcare costs. MedBen was proud to participate, with its sales team delivering...
Sep 22, 2025 | Cost Savings, Drug costs, MedBen Rx, Pharmacy, Pharmacy Benefits Manager (PBM), Prescription, Rx Costs, Savings, Transparency
Across the country, more employers are moving away from traditional pharmacy benefit managers in favor of transparent solutions. MedBen Rx has been ahead of this trend for years, offering clients clarity and lower costs that others are only now beginning to seek. A...
Jul 29, 2025 | biologics, Biosimilars, Cost Savings, MedBen Rx, Pharmacy, Pharmacy Benefits Manager (PBM), Prescription, Rx Costs, Savings
The advantages of biosimilars – clinically equivalent versions of high-price biologic drugs – have been known for years. But despite their growing availability, adoption remains slow… in no small part because major PBMs are stifling uptake....
